Astrana Health Inc 2026年季度报告

Astrana Health, Inc. (Exact name of registrant as specified in its charter)Delaware95-4472349(State or Other Jurisdiction(I.R.S. Employerof Incorporation or Organization)Identification Number) 1668 S. Garfield Avenue, 2ndFloor, Alhambra, California 91801(Address of principal executive offices and zip code) (626) 282-0288(Registrant’s telephone number, including area code)Securities registered pursuant to Section 12(b) of the Act: Trading Symbol Name of Each Exchange on Which Registered ASTH Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject tosuch filing requirements for the past 90 days.☒Yes☐No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required tosubmit such files).☒Yes☐No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company,or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerginggrowth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer☒Accelerated filer☐Non-accelerated filer☐Smaller reporting company☐Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying withany new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).☐Yes☒No As of May 4, 2026, there were 55,716,220 shares of common stock of the registrant, $0.001 par value per share, issued and outstanding, whichincludes 6,132,802 treasury shares that are owned by Allied Physicians of California, a Professional Medical Corporation d.b.a. Allied Pacific ofCalifornia IPA (“APC”), a consolidated affiliate of Astrana Health, Inc. These shares are legally issued and outstanding but treated as treasuryshares for accounting purposes. Astrana Health, Inc. INDEX TO FORM 10-Q FILING TABLE OF CONTENTS PAGEGlossary3Introductory Note4Note About Forward-Looking Statements4 ITEM 1Condensed Consolidated Financial Statements6Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 20256Condensed Consolidated Statements of Income for the three months ended March 31, 2026and 20257Condensed Consolidated Statements of Mezzanine Deficit and Stockholders’ Equity for thethree months ended March 31, 2026 and 20258Condensed Consolidated Statements of Cash Flows for the three months ended March 31,2026 and 20259Notes to Condensed Consolidated Financial Statements10ITEM 2Management’s Discussion and Analysis of Financial Condition and Results of Operations37ITEM 3Quantitative and Qualitative Disclosures about Market Risk48ITEM 4Controls and Procedures48 ITEM 1Legal Proceedings49ITEM 1ARisk Factors49ITEM 2Unregistered Sales of Equity Securities and Use of Proceeds50ITEM 3Defaults Upon Senior Securities50ITEM 4Mine Safety Disclosures50ITEM 5Other Information50ITEM 6Exhibits51SIGNATURES53 Glossary The following abbreviations or acronyms that may be used in this document shall have the adjacent meanings set forth below: Table of Contents INTRODUCTORY NOTE Unless the context dictates otherwise, references in this Quarterly Report on Form 10-Q to the “Company,” “we,” “us,” “our,” andsimilar words are references to Astrana Health, Inc., a Delaware corporation (“Astrana” or “Astrana Health”), and its consolidatedsubsidiaries and affiliated entities, as appropriate, including its consolidated variable interest entities (“VIEs”). This Quarterly Report on Form 10-Q includes the financial statements for the quarter ended March 31, 2026, and providesmanagement’s discussion and analysis of the Company’s financial condition, results of operations, and other required disclosures,as mandated by the Securities and Exchange Commission (the “SEC”). The Centers for Medicare & Medicaid Services (“CMS”) have not reviewed any statements contained in this Report, includingstatements describing the Company’s participation in the ACO Realizing Equity, Access, and Community Health Model (“ACOREACH Model”), in the ACO Long-Term Enhanced ACO Design Model (“ACO LEAD Model”), or in the Medicare SharedSavings Program (“MSSP”). Trade names and trademarks of Astrana and its subsidiaries referred to herein, and their respective logos, are our property. ThisQuarterly Report on Form 10-Q may contain additional trade names and/or trademarks of ot